Studies of AR chromatin binding by chromatin immunoprecipitation (ChIP) approaches like ChIP-on-chip or ChIP in combination with next generation sequencing (ChIP-Seq) have shed light onto the mechanisms of global regulation of AR activities in prostate cancer cell lines or tissues. This evidence concerns the gene AR and prostate cancer.